2017 American Transplant Congress » Poster Session B: Lung Transplantation Poster Session

Date: Sunday, April 30, 2017

Time: 6:00pm-7:00pm

Location: Hall D1

Session Type: Poster Session

Meeting: 2017 American Transplant Congress

6:00pm-7:00pm: Age and Gender Disparities in Post-Lung Transplant Mortality.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

6:00pm-7:00pm: Age and Race Disparities Among Pediatric and Adult Cystic Fibrosis Lung Transplant Recipients.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

6:00pm-7:00pm: C4d Immunohistochemistry in Lung Allograft Interstitial Capillaries Lacks Linear Correlation with Donor Specific Antibodies, yet It Is Still Diagnostically Relevant.

Y. Butt,¹ T. Gokaslan,¹ V. Kaza,² F. Torres,² J. Torrealba.¹

6:00pm-7:00pm: Donor Smoking History Associated with Increased Risk of Death Following Lung Transplantation, but Lower Risk of Bronchiolitis Obliterans Syndrome.

S. Burger, M. Eberlein, J. Keech, E. Arshava, T. Pena, S. Larson, J. Klesney-Tait, K. Parekh.

6:00pm-7:00pm: Echinocandins in Lung Transplant Recipients (LTRs).

Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹

6:00pm-7:00pm: Effect of Statins on Influenza Vaccine Antibody Concentrations in Lung Transplant Recipients.

A. Condon,¹ C. Garmoe,² M. Hayney.²

6:00pm-7:00pm: Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.

O. Timofeeva,¹ M. Kashem,² S. Geier,¹ D. Grogan,² S. Keshavamurthy,² J. Gomez-Abraham,² Y. Toyoda,² F. Cordova.²

6:00pm-7:00pm: Felodipine Diminishes Decline in Glomerular Filtration Rate in Lung Transplanted Patients Treated with Cyclosporine: A Randomized Placebo Controlled Trial.

M. Hornum,¹ M. Iversen,² P. Oturai,³ M. Andersen,² M. Zemtsovski,⁴ P. Bredahl,⁴ N. Bjarnason,² K. Christiansen,⁵ J. Carlsen,² C. Møller,⁶ B. Feldt-Rasmussen,¹ M. Perch.²

6:00pm-7:00pm: HLA, ANA, and ANCA Negative Vasculitis in Lung Transplantation Due to Overexpression of α1 Collagen V.

E. Daoud,¹ Y. Butt,¹ F. Torres,² T. Jose.¹

6:00pm-7:00pm: Impact of Pediatric Lung Transplant on Quality of Life Outcomes.

T. Lazor,¹ H. Grasemann,^2,3,4 M. Solomon,^2,3,4 S. Anthony.^1,4,5,6

6:00pm-7:00pm: Improving Vaccination Rates for Lung Transplant Candidates.

M. Cortez,¹ R. Bag,² L. Potter.¹

6:00pm-7:00pm: Is Lung Allocation Score Associated with Waitlist and Post-Transplant Survival?

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

6:00pm-7:00pm: Is the Time of Appearance and Resolution of De Novo HLA-DP Donor Specific Antibodies Associated with Reduced Deleterious Effect on Lung Transplant Outcomes?

A. Zhang,¹ Y. Sun,² K. McCurry,³ M. Budev.³

6:00pm-7:00pm: Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.

K. Freischlag,¹ B. Ezekian,² M. Mulvihill,² S. Knechtle.²

6:00pm-7:00pm: Lung Transplant Recipient Travel Distance to Transplant Center Does Not Impact Survival.

W. Tsuang,¹ S. Lin,² J. Schold,² M. Valapour.¹

6:00pm-7:00pm: Outcomes After Lung Transplant: Being a Teenager Does Not Stop at Age 18.

R. Baker,¹ R. Rizwan,¹ R. Bryant III,¹ M. Schecter,² C. Towe,² J. Tweddell,¹ F. Zafar,¹ D. Morales.¹

6:00pm-7:00pm: Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.

J. Halldorson,¹ K. AlQahtani.²

6:00pm-7:00pm: Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.

S. Biswas Roy,¹ M. Olson,² D. Harned,¹ P. Kang,³ R. Panchanathan,³ A. Hashimi,¹ J. Huang,¹ H. Abdelrazek,¹ V. Patel,¹ A. Omar,¹ R. Bremner,¹ M. Smith,¹ R. Walia,¹ A. Kalya.⁴

6:00pm-7:00pm: Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.

A. Kashem,¹ S. Keshavamurthy,¹ J. Gomez-Abraham,¹ T. Yoshizumi,¹ H. Zhao,² F. Cordova,³ G. Criner,³ Y. Toyoda.¹

6:00pm-7:00pm: Risk of Venous Thromboembolism After Lung Transplant.

R. Felkner,¹ A. Condon,² K. Rolling,³ M. Hayney.³

6:00pm-7:00pm: Role of HMG CoA Reductase Inhibitors on Time to Development of Chronic Lung Allograft Dysfunction Post-Lung Transplant.

A. Szczepanik, A. Hulbert, H. Lee, C. Benedetti, L. Snyder, J. Byrns.

6:00pm-7:00pm: The Impact of Insurance Status on Waiting List and Post-Lung Transplant Survival in Patients with Cystic Fibrosis.

C. Lehr,¹ M. Skeans,² E. Dasenbrook,¹ M. Valapour.^1,2

6:00pm-7:00pm: The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.

H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.

6:00pm-7:00pm: Waitlist and Post-Lung Transplant Mortality Vary by Diagnosis for a Given Lung Allocation Score.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

« View all sessions from the 2017 American Transplant Congress